Cigna was the fifth of the “Big Six Payors” to report earnings on Thursday before the market opened. Overall, it was a great call by David Cordani, as they have significant growth drivers going forward in the commercial market with biosimilars, specialty pharmacy, and they have managed to elude the government lines of business. They generated $60.5 bill…
Keep reading with a 7-day free trial
Subscribe to The Healthcare Economy to keep reading this post and get 7 days of free access to the full post archives.